The company
Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing treatments for our patients.

Celgene have 8.000 employees globally and have operations in 70 countries with manufacturing facilities in the US and EU. The key research facilities are located in New Jersey, California, Massachusetts and Spain.

COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE

At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
“At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients.”
There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with inflammatory conditions as well as incurable hematological and solid tumor cancers. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.
For further information about Celgene, please visit http://www.celgene.se and http://www.celgene.com.

The Nordic Organisation
The Celgene Nordic team consist of approximately 100 employees with Nordic headquarters in Sweden (Kista outside Stockholm). There are also local Celgene offices in each Nordic country (localized in each capital). The Nordic organisation consist of a broad based mixture of functions and specialists such as Medical, Sales, Marketing, Market Access, Corporate Affairs, QA, Clinical trials, Safety, Compliance, General management, Finance, HR and others. Some resources are shared within the Nordics and others are primarily local resources.

Celgene reinvest into local research in the Nordic. There are currently 45 ongoing Investor Initiated Trials (IIT) in the Nordic with nearly 2.000 patients enrolled in more than 100 sites. The Celgene Clinical Development Trials programme includes 34 Clinical trials with currently 308 patients enrolled in 149 sites. We have currently 21 Clinical Development trials in different phases that are in start-up, ongoing or in follow up phase. Since 2007 we have had 49 trials in the Nordic with 364 patients enrolled. Today we have 80 sites participating in our trials.


The Medical department Nordic has about 30 employees with primary focus on Medical affairs, Drug safety, Clinical research, Clinical trials, Medical information and Real World data. This in selected, prioritized therapeutic areas; Rheumatology, Dermatology, Neurology (Inflammation and Immunology), Oncology and Hematology All the diversity and the overall specialist competencies in the organisation creates a solid environment for a fruitful collaboration, both in the Nordic as well as locally.

Celgene Sweden has a good position and a positive development. The Swedish team consists of dedicated professionals, specialized in Medical affairs, Market Access, Corporate affairs and Sales. The Swedish team is highly skilled and experienced with a well established cross functional collaboration.

There are currently 4 people in the Nordic medical Inflammation and Immunology team located in Sweden and Finland (3 RMLs, and the Manager Medical Affairs I&I Nordic).

About psoriasis and psoriatic arthritis
Helping to address unmet needs of people with psoriasis and psoriatic arthritis.
Psoriasis is a common, chronic skin condition that affects nearly 125 million people worldwide, and results in increased skin cell growth that may appear on the skin as raised, sometimes red, patches covered with a silvery buildup of dead skin cells. Additionally, approximately 38 million live with psoriatic arthritis — a potentially debilitating disease that involves significant pain to swelling in joints — and whose symptoms can impact a person’s everyday life, including common day-to-day activities.
As an emerging leader in the treatment of immune-mediated inflammatory conditions, Celgene continues to deliver groundbreaking work to address areas of unmet need, including for patients around the world living with psoriasis and psoriatic arthritis.
For more information about psoriasis and psoriatic arthritis, please visit http://www.celgene.se or http://www.celgene.com.

Otezla® (apremilast)

Otezla is a novel pharmaceutical (introduced in the market 2015), belonging to a new class for the treatment indications Plaque Psoriasis and Psoriatic Arthritis. Otezla is reimbursed in Sweden for patients that are meeting the indication criteria.

Plaque Psoriasis
OTEZLA is indicated for the treatment of moderate to severe chronic Plaque Psoriasis in adult patients who failed to respond to or who have a contraindication to, or are intolerant to other systemic therapy including cyclosporine, methotrexate or psoralen and ultraviolet-A light (PUVA). For treatment of Plaque Psoriasis in Sweden, OTEZLA is reimbursed according to indication.

Psoriatic Arthritis
OTEZLA, alone or in combination with Disease Modifying Antirheumatic Drugs (DMARDs), is indicated for the treatment of active Psoriatic Arthritis (PsA) in adult patients who have had an inadequate response or who have been intolerant to a prior DMARD therapy. For treatment of active Psoriatic Arthritis in Sweden, OTEZLA is reimbursed according to indication, but with the limitation only in monotherapy.

For more information about OTEZLA, please visit http://www.otezla.se or http://www.otezla.com.

 

Regional Medical Liaison Inflammation and Immunology, Sweden

Broad medical responsibility in Celgene an attractive research based specialty pharma company

The position

Position: Regional Medical Liaison (RML) Inflammation and Immunology (I&I) Sweden

Supervisor: Senior Manager Medical Affairs I&I Rheumatology & Dermatology, Nordics

Department: Medical department

Location: Stockholm area, preferably with the possibility of daily access to the Celgene Nordic office in Kista outside Stockholm.

The Regional Medical Liaison Sweden (RML) is the local scientific expert who drives and executes medical and scientific communication and activities, including Investigator Initiated trials (IITs) in collaboration with external stakeholders and in line with the Celgene business strategy for the Rheumatology and Dermatology area. In addition, the RML develops and maintain relationships with key thought leaders (KTLs) and build an advocacy base among external specialists within the Rheumatology and Dermatology therapeutic areas.

Opportunities with the role

• To represent Celgene, a leading global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing treatments for our patients
• Work in an innovative, expansive, dynamic and values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses
• Having the opportunity to work with Otezla a novel state of the art treatment with high potential for Plaque Psoriasis and Psoriatic Arthritis
• Having the possibility to implement new ideas and projects with influence of company development
• Be part of a Nordic/Swedish team, with deep knowledge, highly motivated, and with a good cooperation and positive atmosphere
• Celgene has an attractive company culture with excellent opportunities for professional and personal development.

Experience, qualifications and competencies

Required experience, skills and qualifications
• Academic, scientific or medical degree, Pharm D, Msc and/or PhD in life sciences, or equivalent
• Experience from Medical Affairs or a similar position in the pharmaceutical industry is desirable
• Alternatively a Research based profile with a PhD and the motivation and talent to develop into the Regional Medical Liaison role
• Experience in dermatology, rheumatology, immunology, or other therapeutic area is an advantage
• Excellent verbal and written communication skills in English and Swedish. Knowledge in Swedish is an advantage.
• Advanced computer skills (MS office).
• Clean, valid drivers license
• Frequent travelling to customers in Sweden, medical Congresses, internal meetings in the Nordic and Europe.

Critical Competencies for success

Scientific communication ability
Ability to quickly absorb scientific and medical data and adjust communication level depending on stakeholder’s level of expertise

Strong in collaboration- and people relation building
A top-class team player. Works effectively in a team-based organization, collaborates cross-functionally and builds alignment around goals and objectives. Readily builds consensus and achieves agreement on key initiatives and priorities. A strong ability to create and maintain relationships with KOLs.

Selfdriven
Ability to work independently. Self-motivated and organized. Taking initiatives for new projects, solving problems, take decisions and create solutions to customer challenges.

Results orientation and customer focus
A result oriented individual, with a participative, strong personal work ethic, intense focus on results and a bias toward action. Focuses on customer needs and satisfaction, Sets high standards for quality and quantity. Establishes clear expectations, objectives and priorities. Diligently monitors progress and proactively addresses variances. Highly decisive and action-oriented.

Contact
For inquires and more information about the position, please contact Magnus Klingberg, Senior Recruitment Consultant or Jenny Ringh, Senior Recruitment Consultant at PeakSearch.
Apply for the position at http://www.peaksearch.se.

Contact details
Magnus Klingberg
e-mail: magnus.klingberg@peaksearch.se
mobile: +46 (0)70-678 09 92 office telephone:+46 (0)8-545 00 100

Jenny Ringh
Email: jenny@peaksearch.se
Mobile: +46-(0)70-235 81 99, telephone: +46-(0)8-545 00 100
webb: http://www.peaksearch.se

PeakSearch is a recruitment consultant company specialized in recruiting Executives, Managers and Specialists in the Nordics. We have developed a top quality recruitment model to attract, select and deliver the optimal match to our candidates and clients.Our talent network is huge and all our consultants have a long experience from the industry. PeakSearch headquarters is situated in central Stockholm, with affiliates in Lund (Sweden), Uppsala (Sweden), and selected partners in the Nordic countries.